Medicine & Health

Nupam Mahajan has been named the inaugural Urologic Surgery Research Professor at Washington University School of Medicine in St. Louis. Mahajan received the honor in recognition of his research advances on the genetic basis of prostate cancer.

The Lymphoma Research Foundation has appointed Todd Fehniger, MD, PhD, a professor of medicine at Washington University School of Medicine in St. Louis, to its scientific advisory board.

Washington University School of Medicine researchers have found that the immune system can be its own worst enemy in the fight against cancer. In a new study in mice, they found that a subset of immune cells inadvertently dampens cancer immunotherapy.

School of Medicine researchers have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer.

Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells — cells that have stopped dividing and drive inflammation — may play important roles in suppressing the immune system and allowing such tumors to grow unchecked.

Hematologist Amy Zhou, MD, an associate professor at the School of Medicine, values the connections she makes with patients. She is also pursuing research to improve blood cancer treatments.

John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Endowed Professor of Medicine at Washington University School of Medicine in St. Louis, has received the Chancellor’s Award for Innovation and Entrepreneurship for his research contributions.

Researchers at Washington University School of Medicine in St. Louis have found that a strain of gut bacteria can boost immune responses and enhance cancer immunotherapy to fight sarcoma tumors in mice.

A study from biologists and clinicians at Washington University in St. Louis reports that glioblastoma cells have built-in circadian rhythms that create better times of day for treatment.

Researchers at the School of Medicine have received a $5 million grant from the Leukemia & Lymphoma Society to support research aimed at developing new immunotherapies for different types of blood-based cancers.